India to France: Clindamycin Export Trade Route

The India to France Clindamycin corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $1.3M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $112.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 23.5%, placing it at rank #7 among India's top clindamycin export destinations globally.

On the import side, key buyers of Indian clindamycin in France include SUBSTIPHARM, EURIMEX PHARMA, EURIMEX PHARMA . SUBSTIPHARM is the single largest importer with 3 shipments valued at $1.1M USD.

India's clindamycin exports to France are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED, MEDNEXT PHARMA PRIVATE LIMITED, MEDNEXT BIOTECH LIMITED — together account for 95% of total trade value on this route. The average shipment value of $112.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as clindamycin phosphate gel usp 1% (aclingel) and aclin gel 15gm clindamycin phosphate gel usp 1%, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUBSTIPHARM is the largest importer with 3 shipments worth $1.1M USD — representing 79% of all clindamycin imports from India on this route.